BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 27712767)

  • 1. Mechanisms of Benefit with Aspirin Therapy in Aspirin-Exacerbated Respiratory Disease.
    Hill J; Burnett T; Katial R
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):735-747. PubMed ID: 27712767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of aspirin desensitization.
    Burnett T; Katial R; Alam R
    Immunol Allergy Clin North Am; 2013 May; 33(2):223-36. PubMed ID: 23639710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performing Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease.
    Waldram JD; Simon RA
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):693-703. PubMed ID: 27712764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization.
    Steinke JW; Culp JA; Kropf E; Borish L
    J Allergy Clin Immunol; 2009 Oct; 124(4):724-30.e4. PubMed ID: 19767084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aspirin desensitization in the management of aspirin-exacerbated respiratory disease.
    Tajudeen BA; Schwartz JS; Bosso JV
    Curr Opin Otolaryngol Head Neck Surg; 2017 Feb; 25(1):30-34. PubMed ID: 27849653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the management of aspirin-exacerbated respiratory disease.
    Lee JH; Jung CG; Park HS
    Expert Rev Respir Med; 2018 Feb; 12(2):137-143. PubMed ID: 29249187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease.
    Steinke JW; Payne SC; Borish L
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors driving the aspirin exacerbated respiratory disease phenotype.
    Steinke JW; Borish L
    Am J Rhinol Allergy; 2015; 29(1):35-40. PubMed ID: 25590316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
    Williams AN
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases.
    Katial RK; Strand M; Prasertsuntarasai T; Leung R; Zheng W; Alam R
    J Allergy Clin Immunol; 2010 Oct; 126(4):738-44. PubMed ID: 20728206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin desensitization in aspirin-exacerbated respiratory disease.
    White AA; Stevenson DD
    Immunol Allergy Clin North Am; 2013 May; 33(2):211-22. PubMed ID: 23639709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
    Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
    J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin-exacerbated respiratory disease: update on pathogenesis and desensitization.
    White AA; Stevenson DD
    Semin Respir Crit Care Med; 2012 Dec; 33(6):588-94. PubMed ID: 23047310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical updates in aspirin-exacerbated respiratory disease.
    Laidlaw TM
    Allergy Asthma Proc; 2019 Jan; 40(1):4-6. PubMed ID: 30582489
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse respiratory reactions to aspirin and nonsteroidal anti-inflammatory drugs.
    Simon RA
    Curr Allergy Asthma Rep; 2004 Jan; 4(1):17-24. PubMed ID: 14680616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.